Vancouver, British Columbia--(Newsfile Corp. - December 18, 2018) - Rapid Dose Therapeutics (CSE: DOSE) is one of the
latest new listing on the Canadian Securities Exchange, following a reverse takeover of TSX Venture Exchange listed Acme Resources.
The company, through its subsidiaries, provides proprietary enhanced drug delivery technologies.
InvestmentPitch Media has produced a "video" which provides a brief overview of the
company. If this link is not enabled, please visit www.InvestmentPitch.com and enter
"Rapid Dose" in the search box.
Through its subsidiary, it owns a proprietary oral fast-dissolving drug delivery system, QuickStrip™. By placing the strip under
the tongue, inside the cheek, or directly on the tongue and allowing it to dissolve for a few seconds, the active molecule is
released from the strip and rapidly delivered across the tissue into the blood stream. The advantage of this type of delivery is
that the active ingredient avoids being degraded by dissolution in the highly acidic environment of the stomach, or modified by
first-pass metabolism in the liver.
QuickStrip is capable of rapidly releasing a variety of pharmaceuticals, emulsified oils and over-the-counter medicines directly
into the blood stream. The proprietary oral and non-invasive drug delivery technology is designed for applications of
nutraceuticals, cannabis, active pharmaceutical ingredients, and other healthcare products. The company has recently started
selling natural healthcare products including vitamin B12 and caffeine in Canada and the United States.
Mark Upsdell, CEO, stated: "The RDT team is excited to begin trading on the Canadian Securities Exchange today. The RDT team
is grateful to the former directors and officers of ACME Resources Corp. and to its shareholders for the genesis to what is
a culmination of two years of efforts to create a world class bio-technology company. We would also like to express our gratitude
to all those stakeholders and participants who have helped us reach this day, including but not limited to our industry
partners, investors and advisors. We look forward to implementing our marketing and development strategy in order to realize the
growth potential of this enterprise."
As of August 31, 2018, the company had a cash balance of $6,037,000 following private placement financings which raised gross
proceeds of $7,056,000.
For more information, please visit the company's website at www.rapid-dose.com, contact
Mark Upsdell, CEO, at 416-477-1052 or email info@rapid-dose.com.
About InvestmentPitch Media
InvestmentPitch Media leverages the power of video, which together with its extensive distribution, positions a company's story
ahead of the 1,000's of companies seeking awareness and funding from the financial community. The company specializes in producing
short videos based on significant news releases, research reports and other content of interest to investors.
CONTACT:
InvestmentPitch Media
Barry Morgan, CFO
bmorgan@investmentpitch.com